Journal of Equine Veterinary Science
Volume 28, Issue 5 , Pages 295-300, May 2008

Guaifenesin-Ketamine-Xylazine Infusions to Provide Anesthesia in Donkeys

  • Ethel V. Taylor, DVM

      Affiliations

    • Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX
    • Corresponding Author InformationReprint requests: Ethel V. Taylor, DVM, Department of Diagnostic Medicine/Pathobiology, 308 Coles Hall, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506.
  • ,
  • Courtney L. Baetge, DVM

      Affiliations

    • Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX
  • ,
  • Nora S. Matthews, DVM

      Affiliations

    • Department of Large Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX
  • ,
  • Tex S. Taylor, DVM

      Affiliations

    • Department of Large Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX
  • ,
  • Kerry S. Barling, DVM, PhD

      Affiliations

    • Department of Barling Veterinary Services, Iola, TX

Abstract 

The purpose of this study was to determine a satisfactory combination of guaifenesin, ketamine, and xylazine (GKX) that would produce safe and satisfactory total intravenous anesthesia in donkeys for use under field conditions. Donkeys require higher amounts of ketamine in GKX to achieve satisfactory anesthetic levels without producing excessive depression with guaifenesin. Five adult standard donkeys (average weight, 264 kg) were anesthetized with 1.5 mg/mL ketamine, 0.5 mg/mL xylazine, 50 mg/mL guaifenesin (GKX-1); 2.0 mg/mL ketamine, 0.5 mg/mL xylazine, 50 mg/mL guaifenesin (GKX-2); or 2.0 mg/mL ketamine, 0.75 mg/mL xylazine, 50 mg/mL guaifenesin (GKX-3). For the first trial, two donkeys received GKX-1, two received GKX-2, and one received GKX-3. One donkey received GKX-1, one received GKX-2, and three received GKX-3 for the second trial. In the final trial, two received GKX-1, two received GKX-2, and one received GKX-3. Donkeys were sedated with xylazine (1.1 mg/kg body weight) intravenously, and anesthesia was induced using intravenous GKX-1, GKX-2, or GKX-3. Anesthesia was maintained for 45 minutes; temperature, respiration rate, heart rate, hemoglobin saturation, partial pressure of arterial oxygen (PaO2), partial pressure of carbon dioxide in arterial gas (PaCO2), and pH were measured. There was no significant difference between combinations for temperature, respiration rate, heart rate, hemoglobin saturation, PaCO2, or pH. At 30 and 45 minutes, GKX-3 produced significantly (P < .05) lower PaO2 values than GKX-1 and GKX-2. GKX-3 is not recommended for field use in donkeys because of respiratory depression (PaO2= 48.7 [±5.84] and 46.0 ± 3.11 mmHg at 30 and 45 minutes, respectively), whereas more voluntary movement was apparent with GKX-1. GKX-2 produced satisfactory anesthesia without significant respiratory depression in donkeys and should produce safe and effective anesthesia in donkeys under field conditions.

Keywords: Guaifenesin-ketamine-xylazine, GKX, Donkey, Intravenous anesthesia, Equine

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 15.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Refereed

PII: S0737-0806(08)00097-X

doi:10.1016/j.jevs.2008.03.004

Journal of Equine Veterinary Science
Volume 28, Issue 5 , Pages 295-300, May 2008